About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Diversity & Inclusion
Brighter Future Award
Archivio
Darunavir population pharmacokinetics in pregnancy
HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds
I was like, oh my God, what happens if it doesn’t work’? Young people living with HIV, clinical trial participation and the truth economy
Raltegravir in HIV-1 Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy
Ritonavir pharmacokinetics in pregnancy
Etravirine pharmacokinetics during pregnancy and postpartum
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV
Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?
“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission
“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV
Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?
‘I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV; accepted for presentation at AIDS Impact
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update Decemebr 2014
Pediatric drug safety surveillance in FDA-AERS: a description of adverse events from GRIP project.
Treating hepatitis C virus in children: time for a new paradigm